Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FQ2AD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,813
Award facts
- Contract value 100% obligated
- $16,812.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,812.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Kevzara (sarilumab) 200 mg/1.14 mL pen injections. This contract represents a non-set-aside competitive award with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kevzara is a biologic medication used to treat rheumatoid arthritis and is part of the Department of Defense's broader pharmaceutical procurement strategy to support military healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military health programs globally. AmerisourceBergen's continued selection through competitive awards reflects its established capability to meet federal medical procurement requirements and serve various government healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FQ2AD?
SPE2DB25FQ2AD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FQ2AD worth?
The government has obligated $16,813 on SPE2DB25FQ2AD.
Is contract SPE2DB25FQ2AD an order under another contract?
Yes. SPE2DB25FQ2AD is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2AD competed?
The extent of competition for SPE2DB25FQ2AD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award